亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Response to: ‘High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?’ by Inancet al

医学 抗磷脂综合征 免疫学 痹症科 结缔组织病 皮肤病科 内科学 自身免疫性疾病 抗体
作者
James Cheng‐Chung Wei,Fang Xiao Zhu,Jing‐Yang Huang
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:81 (7): e111-e111 被引量:1
标识
DOI:10.1136/annrheumdis-2020-218402
摘要

Response to: 'High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?' by Inanc et alWe thank Inanc et al 1 for their comments on our article entitled 'Risk of systemic lupus erythematosus (SLE) in patients with idiopathic thrombocytopenic purpura (ITP): a population-based cohort study'.In our article, we concluded that ITP is strongly associated with incidental SLE. 2 We agree with Inanc et al 1 that antiphospholipid syndrome (APS) is an important effect modifier in ITP and SLE.We also acknowledge that Inanc et al 1 addressed the difference of APS (2.77% in the ITP group vs 0.02% in the non-ITP controls) in table 1 of our article. 2Actually, ITP, APS and SLE sometimes overlapped in clinical practice.As in table 1, there are more baseline comorbidities in the ITP group, including thrombotic event, cardiovascular disease and ITP.Hence, we did propensity score to match these differences rather than exclude these comorbidities in patient selection as in figure 1.The reason for this is that once you exclude these effect modifiers, then you cannot study their effects.Thus, we prefer matching and stratified analysis on important effect modifiers, rather than exclusion. 3s Inanc et al 1 mentioned, many claim-based or patientreported databases have concerns of validity and uncertainty.Unfortunately, the National Taiwan Insurance Research Database (NHIRD) did not provide laboratory data, such as antinuclear antibody (ANA) and APS profiles.Although this is a limitation, the NHIRD had been validated and appreciated in many high impact publications. 4 5 In our study, we had tried to minimise this information bias by adding sensitivity tests and also stratifies analysis on important confounders, such as thrombosis cardiovascular disease and some infections and life stylerelated diseases to reduce the bias from comorbidities, including APS.These had been discussed in-depth in Discussion section of our article.We agree that APS clinical features and laboratory profiles and ANA are important baseline evaluation for every patient with ITP.It is also indeed our study purpose and conclusion.Furthermore, even though baseline ANA and aPL were negative, we suggest that patients with ITP should still be monitored yearly for clinical and serological lupus or APS.We hope this clinical application will improve the quality of our daily practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脑洞疼应助李小猫采纳,获得10
10秒前
16秒前
李小猫完成签到,获得积分10
18秒前
20秒前
李小猫发布了新的文献求助10
22秒前
57秒前
1分钟前
1分钟前
2分钟前
3分钟前
Tiger完成签到,获得积分10
3分钟前
3分钟前
3分钟前
Ma发布了新的文献求助10
3分钟前
4分钟前
4分钟前
科研通AI5应助Ma采纳,获得10
4分钟前
彼岸花开发布了新的文献求助10
4分钟前
4分钟前
易四夕发布了新的文献求助10
4分钟前
5分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
Ma发布了新的文献求助10
5分钟前
1234完成签到,获得积分10
5分钟前
岁和景明完成签到 ,获得积分10
5分钟前
科研通AI5应助Ma采纳,获得10
5分钟前
西蓝花香菜完成签到 ,获得积分10
5分钟前
6分钟前
6分钟前
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
Ma发布了新的文献求助10
7分钟前
7分钟前
科研通AI5应助Ma采纳,获得10
7分钟前
忧伤的绍辉完成签到 ,获得积分10
7分钟前
隐形曼青应助易四夕采纳,获得10
7分钟前
8分钟前
易四夕发布了新的文献求助10
8分钟前
8分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968504
求助须知:如何正确求助?哪些是违规求助? 3513278
关于积分的说明 11167214
捐赠科研通 3248660
什么是DOI,文献DOI怎么找? 1794386
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804638